Ferroptosis Regulator Information
General Information of the Ferroptosis Regulator (ID: REG10020)
Full List of the Ferroptosis Target of This Regulator and Corresponding Disease/Drug Response(s)
KDM6B
can regulate the following target(s), and cause disease/drug response(s). You can browse detail information of target(s) or disease/drug response(s).
Browse Target
Browse Disease
Nuclear factor erythroid 2-related factor 2 (NFE2L2) [Suppressor; Marker]
In total 1 item(s) under this target | |||||
Experiment 1 Reporting the Ferroptosis Target of This Regulator | [1] | ||||
Target for Ferroptosis | Marker/Suppressor | ||||
Responsed Disease | Lung injury | ICD-11: NB32 | |||
Pathway Response | Fatty acid metabolism | hsa01212 | |||
Ferroptosis | hsa04216 | ||||
Cell Process | Cell ferroptosis | ||||
In Vitro Model |
A-549 cells | Lung adenocarcinoma | Homo sapiens | CVCL_0023 | |
R-3327-AT-2 cells | Prostate adenocarcinoma | Rattus norvegicus | CVCL_L303 | ||
In Vivo Model |
A total of 30 male C57/B6J mice (8-10 weeks, 21-23 g) were acquired from Chinese Academy of Medical Sciences (Beijing, China). The sepsis-induced ALI model was constructed by administering LPS intratracheally (5 mg/kg) for 12 h as previously reported. The control groups were given an isovolumetric sterile saline. Then, 12 h after LPS installation, the animals were sacrificed by cervical dislocation under deep anesthesia with an intraperitoneal injection of 2% sodium pentobarbital (60 mg/kg).
Click to Show/Hide
|
||||
Response regulation | JMJD3 ( KDM6B) deficiency may relieve LPS-induced acute lung injury (ALI) by blocking alveolar epithelial ferroptosis in a Nrf2 dependent manner, which may serve as a novel therapeutic target against ALI. | ||||
Lung injury [ICD-11: NB32]
In total 1 item(s) under this disease | |||||
Experiment 1 Reporting the Ferroptosis-centered Disease Response | [1] | ||||
Target Regulator | Lysine-specific demethylase 6B (KDM6B) | Protein coding | |||
Pathway Response | Fatty acid metabolism | hsa01212 | |||
Ferroptosis | hsa04216 | ||||
Cell Process | Cell ferroptosis | ||||
In Vitro Model |
A-549 cells | Lung adenocarcinoma | Homo sapiens | CVCL_0023 | |
R-3327-AT-2 cells | Prostate adenocarcinoma | Rattus norvegicus | CVCL_L303 | ||
In Vivo Model |
A total of 30 male C57/B6J mice (8-10 weeks, 21-23 g) were acquired from Chinese Academy of Medical Sciences (Beijing, China). The sepsis-induced ALI model was constructed by administering LPS intratracheally (5 mg/kg) for 12 h as previously reported. The control groups were given an isovolumetric sterile saline. Then, 12 h after LPS installation, the animals were sacrificed by cervical dislocation under deep anesthesia with an intraperitoneal injection of 2% sodium pentobarbital (60 mg/kg).
Click to Show/Hide
|
||||
Response regulation | JMJD3 ( KDM6B) deficiency may relieve LPS-induced acute lung injury (ALI) by blocking alveolar epithelial ferroptosis in a Nrf2 dependent manner, which may serve as a novel therapeutic target against ALI. | ||||